SIMLO-5

This brand name is authorized in Nigeria.

Active ingredients

The drug SIMLO-5 contains one active pharmaceutical ingredient (API):

1	Losartan UNII 3ST302B24A - LOSARTAN POTASSIUM
	Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.
	Read more about Losartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3445	Tablet	SIMLO-5 TABLETS TAB 50 mg 3x10 tablets	28 RNW-PP-137481 SIMLO-5 TABLETS AMLODIPINE, LOSARTAN POTASSIUM Losartan potassium BP 50.00mg, lactose anhydrous BP 15.00mg, hydroxyl propyl methyl cellulose (E-5) BP 1.00mg, isopropyl alcohol BP 7.50mg, methylene chloride BP 2.50mg, dummy granules IH 33.65mg, amlodipine besilate BP 7.35mg, microcrystalline cellulose (DC) BP 28.00mg, lactose anhydrous BP 11.5mg, talcum BP 5.00mg, magnesium stearate BP 5.00mg B4-3445 Drugs Imported Products 3 x 10 Tablets Prescription Only Medicine (POM) 6/25/2020 LEOTETRA HEALTHCARE LIMITED, LEOTETRA PLACE, PLOT 5, NAIBAWA LAYOUT 8066471561 leotetranigltd@outlook.com INNOVA CAPTAB PVT. LTD, 81-B, EPIP PHASE – 1 JHARMAJRI, BADDI (H.P) PIN – 173205 INDIA. , India	07/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA01	Losartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3445